2,567
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Usefulness of Glucose to Lymphocyte Ratio to Predict in-Hospital Mortality in Patients with AECOPD Admitted to the Intensive Care Unit

, &
Pages 158-165 | Received 03 Oct 2021, Accepted 09 Feb 2022, Published online: 07 Apr 2022

References

  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. DOI:10.1164/rccm.201701-0218PP
  • Buist AS, McBurnie MA, Vollmer WM, BOLD Collaborative Research Group, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. DOI:10.1016/S0140-6736(07)61377-4
  • Hoyert DL, Xu JQ. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61(6):1–65.
  • Groenewegen KH, Schols AM, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459–467. DOI:10.1378/chest.124.2.459
  • Mulpuru S, McKay J, Ronksley PE, et al. Factors contributing to high-cost hospital care for patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007; 24(12):989–995.
  • Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(2):81–89. DOI:10.1513/AnnalsATS.201208-043OC
  • Zhou X, Li Q, Zhou X. Exacerbation of chronic obstructive pulmonary disease. Cell Biochem Biophys. 2015;73(2):349–355. DOI:10.1007/s12013-015-0605-9
  • Groenewegen KH, Postma DS, Hop WC, COSMIC Study Group, et al. Increased systemic inflmmation is a risk factor for COPD exacerbations. Chest. 2008;133(2):350–357. DOI:10.1378/chest.07-1342
  • Sun W, Luo Z, Jin J, et al. The neutrophil/lymphocyte ratio could predict noninvasive mechanical ventilation failure in patients with acute exacerbation of chronic obstructive pulmonary disease: a retrospective observational study. COPD. 2021;16:2267–2277. DOI:10.2147/COPD.S320529
  • Luo Z, Zhang W, Chen L, et al. Prognostic value of neutrophil:Lymphocyte and platelet:Lymphocyte ratios for 28-Day mortality of patients with AECOPD. Int J Gen Med. 2021;14:2839–2848. DOI:10.2147/IJGM.S312045
  • Liu X, Ge H, Feng X, et al. The combination of hemogram indexes to predict exacerbation in stable chronic obstructive pulmonary disease. Front Med (Lausanne). 2020;7:572435. DOI:10.3389/fmed.2020.572435
  • Dai G, Ran Y, Wang J, et al. Clinical differences between eosinophilic and noneosinophilic acute exacerbation of chronic obstructive pulmonary disease: a multicenter cross-sectional Study. Mediators Inflamm. 2020;2020:1059079. DOI:10.1155/2020/1059079
  • Emami Ardestani M, Alavi-Naeini N. Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2021;15(4):382–388. DOI:10.1111/crj.13312
  • Monsour E, Rodriguez LM, Abdelmasih R, et al. Characteristics and outcomes of diabetic patients with acute exacerbation of COPD. J Diabetes Metab Disord. 2021;20(1):461–466. DOI:10.1007/s40200-021-00766-7
  • Lin L, Shi J, Kang J, et al. Analysis of prevalence and prognosis of type 2 diabetes mellitus in patients with acute exacerbation of COPD. BMC Pulm Med. 2021;21(1):7. DOI:10.1186/s12890-020-01371-9
  • Zhang Y, Xu Y, Wang D, et al. Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. Int J Clin Oncol. 2021;26(1):135–144. DOI:10.1007/s10147-020-01782-y
  • Zhong A, Cheng CS, Kai J, et al. Clinical significance of glucose to lymphocyte ratio (GLR) as a prognostic marker for patients with pancreatic Cancer. Front Oncol. 2020;10:520330. DOI:10.3389/fonc.2020.520330
  • Navarro J, Kang I, Hwang HK, et al. Glucose to lymphocyte ratio as a prognostic marker in patients with resected pT2 gallbladder Cancer. J Surg Res. 2019;240:17–29. DOI:10.1016/j.jss.2019.02.043
  • Pollard TJ, Johnson AEW, Raffa JD, et al. The eICU collaborative research database, a freely available multi-center database for critical care research. Sci Data. 2018;5:180178. DOI:10.1038/sdata.2018.178
  • Liu T, Zhao Q, Du B. Effects of high-flow oxygen therapy on patients with hypoxemia after extubation and predictors of reintubation: a retrospective study based on the MIMIC-IV database. BMC Pulm Med. 2021;21(1):160. DOI:10.1186/s12890-021-01526-2
  • Stolz D, Barandun J, Borer H, et al. Diagnosis, prevention and treatment of stable COPD and acute exacerbations of COPD: the swiss recommendations 2018. Respiration. 2018;96(4):382–398. DOI:10.1159/000490551
  • Mohan A, Premanand R, Reddy LN, et al. Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit. BMC Pulm Med. 2006;6(1):27. DOI:10.1186/1471-2466-6-27
  • Warwick M, Fernando SM, Aaron SD, Resource Optimization Network, et al. Outcomes and resource utilization among patients admitted to the intensive care unit following acute exacerbation of chronic obstructive pulmonary disease. J Intensive Care Med. 2021;36(9):1091–1097. DOI:10.1177/0885066620944865
  • Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995;274(23):1852–1857.
  • Raith EP, Udy AA, Bailey M, for the Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE), et al. Australian and New Zealand intensive care society (ANZICS) Centre for outcomes and resource evaluation (CORE). prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-Hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317(3):290–300. DOI:10.1001/jama.2016.20328
  • Jentzer JC, Bennett C, Wiley BM, et al. Predictive value of individual sequential organ failure assessment Sub-scores for mortality in the cardiac intensive care unit. PLoS One. 2019;14(5):e0216177. DOI:10.1371/journal.pone.0216177
  • Yang J, Yang J. Association between blood eosinophils and mortality in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2021;16:281–288. DOI:10.2147/COPD.S289920
  • Yu X, Zhu GP, Cai TF, et al. Establishment of risk prediction model and risk score for in-hospital mortality in patients with AECOPD. Clin Respir J. 2020;14(11):1090–1098. DOI:10.1111/crj.13246
  • Gu Y, Ye X, Liu Y, et al. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Res. 2021;22(1):176. DOI:10.1186/s12931-021-01771-3
  • Chen KY, Wu SM, Tseng CH, et al. Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case-control study. BMC Pulm Med. 2021;21(1):141. DOI:10.1186/s12890-021-01505-7
  • Guo R, Li J, Ma X, et al. The predictive value of neutrophil-to-lymphocyte ratio for chronic obstructive pulmonary disease: a systematic review and Meta-analysis. Expert Rev Respir Med. 2020;14(9):929–936. DOI:10.1080/17476348.2020.1776613
  • Geerdink JX, Simons SO, Pike R, et al. Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype. Respir Res. 2016;17(1):140. DOI:10.1186/s12931-016-0456-y